NeuroBo Pharmaceuticals (NRBO) Institutional Ownership $0.66 +0.01 (+1.82%) As of 07/2/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NeuroBo Pharmaceuticals (NASDAQ:NRBO)CurrentInstitutional OwnershipPercentage1.37%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$3.85MNumber ofInstitutional Sellers(last 12 months)0 Get NRBO Insider Trade Alerts Want to know when executives and insiders are buying or selling NeuroBo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRBO Institutional Buying and Selling by Quarter NeuroBo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/6/2024Ferguson Wellman Capital Management Inc.15,670$50K0.0%N/A0.191% 8/15/2024Armistice Capital LLC696,829$3.37M0.0%N/A14.204% 8/15/2024Affinity Asset Advisors LLC89,222$432K0.0%N/A1.819% 2/14/2022Murchinson Ltd.205,256$251K0.0%N/A0.772% 11/9/2021BlackRock Inc.44,579$166K0.0%-11.3%0.200% 9/3/2021Parametric Portfolio Associates LLC16,530$55K0.0%N/A0.074% 8/16/2021State Street Corp15,878$53K0.0%-78.6%0.071% 8/13/2021Northern Trust Corp24,579$82K0.0%-68.9%0.110% 8/13/2021Vanguard Group Inc.477,918$1.59M0.0%-30.2%2.145% 8/12/2021Advisory Services Network LLC8,550$28K0.0%N/A0.038% 8/12/2021Ergoteles LLC30,800$103K0.0%N/A0.138% 8/11/2021Deutsche Bank AG31,090$104K0.0%+1,016.3%0.140% 8/4/2021Mount Yale Investment Advisors LLC57,425$191K0.0%N/A0.258% 5/18/2021California State Teachers Retirement System9,817$43K0.0%+52.1%0.044% 5/17/2021Goldman Sachs Group Inc.10,056$44K0.0%N/A0.045% 5/13/2021Bank of New York Mellon Corp19,178$84K0.0%N/A0.087% 5/12/2021JPMorgan Chase & Co.18,449$81K0.0%+69.4%0.083% 5/7/2021BlackRock Inc.226,013$995K0.0%+2.7%1.019% (Data available from 1/1/2016 forward) NRBO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRBO shares? During the previous two years, the following institutional investors and hedge funds held shares of NeuroBo Pharmaceuticals shares: Armistice Capital LLC ($3.37M), and Affinity Asset Advisors LLC ($432K), Ferguson Wellman Capital Management Inc. ($50K).Learn more on NeuroBo Pharmaceuticals' institutional investors. What percentage of NeuroBo Pharmaceuticals' stock is owned by institutional investors? 1.37% of NeuroBo Pharmaceuticals' stock is owned by institutional investors. Learn more on NRBO's institutional investor holdings. Which institutional investors have been buying NeuroBo Pharmaceuticals' stock? The following institutional investors have purchased NeuroBo Pharmaceuticals' stock in the last 24 months: Armistice Capital LLC ($696.83K), Affinity Asset Advisors LLC ($89.22K), and Ferguson Wellman Capital Management Inc. ($15.67K). How much institutional buying is happening at NeuroBo Pharmaceuticals? Institutional investors have bought a total of 801,721 shares in the last 24 months. This purchase volume represents approximately $3.85M in transactions. Related Companies BTC Digital Major Shareholders Kentucky First Federal Bancorp Major Shareholders Greenidge Generation Major Shareholders SOS Major Shareholders Sphere 3D Major Shareholders Glen Burnie Bancorp Major Shareholders LM Funding America Major Shareholders Mawson Infrastructure Group Major Shareholders Carver Bancorp Major Shareholders Soluna Major Shareholders This page (NASDAQ:NRBO) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
